Russell Frank Company’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Russell Frank Company’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,800	Closed	-$79K	–	3122
2015 Q4	$79K	Buy	2,800 +1,724	+160%	+$52.1K	﹤0.01%	2836
2015 Q3	$34K	Sell	1,076 -538	-33%	-$25.7K	﹤0.01%	2937
2015 Q2	$96K	Buy	1,614 +1,590	+6,625%	+$112K	﹤0.01%	2910
2015 Q1	$3K	Sell	24 -18,743	-100%	-$1.79M	﹤0.01%	2961
2014 Q4	$1.77M	Buy	18,767 +10,178	+119%	+$971K	﹤0.01%	1860
2014 Q3	$660K	Sell	8,589 -2,286	-21%	-$180K	﹤0.01%	2249
2014 Q2	$818K	Buy	+10,875	New	+$666K	﹤0.01%	2146
2013 Q4	–	Sell	-506	Closed	-$14K	–	3290
2013 Q3	$14K	Buy	506 +500	+8,333%	+$16.1K	﹤0.01%	3266
2013 Q2	$0	Buy	+6	New	+$225	﹤0.01%	3395

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Russell Frank Company's PTX Position: Q1 2016 in Review

Russell Frank Company sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2016, closing a stake of 2,800 shares — an estimated $79K sold.

Russell Frank Company first reported a position in PTX in Q2 2013 and held it in 9 quarters. The position peaked at $1.77M in Q4 2014. 88 funds tracked by Wall St. Rank hold PTX as of Q1 2016.

Russell Frank Company reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2016 after selling out during the quarter.
Russell Frank Company sold 2,800 Pernix Therapeutics Holdings, Inc. shares in Q1 2016, an estimated $79K.
Russell Frank Company first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 9 quarters.
Russell Frank Company's Pernix Therapeutics Holdings, Inc. position peaked at $1.77M in Q4 2014.
88 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.